Main text (Cell Reports 43, 113924; March 26, 2024) In Figure 2D, the authors assessed SUMOylation of V5-tagged HuR WT and lysine-to-arginine mutants within the RRM1-2 domains following nickel-histidine affinity purification. As published, the V5 input image shown in Figure 2D is incorrect. During figure assembly, the V5 input corresponding to Figure 2C was mistakenly included in Figure 2D.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Joris Guyon
Preliminary pharmacokinetic investigation of two discoidin domain receptor 2 inhibitors in murine plasma and brain using liquid chromatography–tandem mass spectrometry analysis
Abstract Owing to its involvement in extracellular matrix–glial cell interactions, discoidin domain receptor 2 (DDR2) has emerged as a promising pharmacological target in various human diseases, including cancers and neurodegenerative disorders. Two allosteric inhibitors, WRG-28 and DDR2-IN-1, selectively target DDR2.
Comparison of Two Strategies of Analysis of Urinary Protein Composition for the Diagnosis and Follow‐Up of Renal Diseases
CKD chronic kidney disease GFR glomerular filtration rate LOD limit of detection LOQ limit of quantification RBP retinol-binding protein UP urine profile 1 Introduction Chronic kidney disease (CKD) is a public health priority [1]. It is defined by the presence of markers of kidney damage for more than 3 months, such as a high protein or albumin/creatinine ratio, or a decline in estimated glomerular filtration rate (GFR) below 60 mL/min/1.73 m2 [2].
Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes - Cancer Gene Therapy
Abstract Mounting evidence is identifying human cytomegalovirus (HCMV) as a potential oncogenic virus. HCMV has been detected in glioblastoma multiforme (GB). Herewith, we present the first experimental evidence for the generation of CMV-Elicited Glioblastoma Cells (CEGBCs) possessing glioblastoma-like traits that lead to the formation of glioblastoma in orthotopically xenografted mice.
Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile
Abstract Glioblastoma (GB) remains one of the most treatment refractory and fatal tumour in humans. GB contains a population of self-renewing stem cells, the brain tumour stem cells (BTSC) that are highly resistant to therapy and are at the origin of tumour relapse. Here, we report, for the first time, that mubritinib potently impairs stemness and growth of patient-derived BTSCs harboring different oncogenic mutations.
GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity - Nature Cancer
Ethics statements Human material was obtained from surgeries performed at the Haukeland University Hospital (Bergen, Norway). Written consent was obtained from individuals with procedures that were approved for the projects (project numbers 013.09 and 151825) by the Regional Ethical Committee. Animal experiments were approved by the Institutional Animal Care and Use Committee of Cleveland Clinic and local ethical committee. Animals were treated in accordance with the Norwegian Animal Act.
Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or Aneurysms
Anticancer drugs targeting angiogenesis act either directly on vascular endothelial growth factor (VEGF) receptors (VEGF inhibitors) or VEGF-mediated intracellular processes (tyrosine kinase inhibitors) or indirectly through downstream VEGF signaling within broader processes (mammalian target of rapamycin inhibitors and multiprotein kinase inhibitors).
A 3D Spheroid Model for Glioblastoma
Cancer Research Fill out the form below to receive a free trial or learn more about access: Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help. An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help. Summary Here, we describe an easy-to-use invasion assay for glioblastoma.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joris
Contact Joris, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack